Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L01AA" (32)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Cyclophosphamide (L01AA01) 4 products
WHO-DDD
DrugBank.ca
IP
CI
Endoxan
-
T
50 Dragée(s)
14.87
32.60
10 %
Dragées: Cyclophosphamidum Anhydricum 50 mg
Baxter AG
A / SL
FB
G
IP
CI
Endoxan 200 mg
Durchstechflasche(n)
4.15
13.75
10 %
Dry substance: Cyclophosphamidum Anhydricum 200 mg
Baxter AG
A / SL
FB
G
IP
CI
Endoxan 500 mg
Durchstechflasche(n)
10.30
27.60
10 %
Dry substance: Cyclophosphamidum Anhydricum 500 mg
Baxter AG
A / SL
FB
G
IP
CI
Endoxan 1 g
Durchstechflasche(n)
20.30
38.50
10 %
Lyophilisate: Cyclophosphamidum Anhydricum 1000 mg
Baxter AG
A / SL
FB
G
Chlorambucil (L01AA02) 1 products
WHO-DDD
DrugBank.ca
IP
CI
Leukeran
25 Tablet(s)
19.80
37.95
10 %
Coated tablets: Chlorambucilum 2 mg
Aspen Pharma Schweiz
GmbH
A / SL
FB
G
Melphalan (L01AA03) 5 products
WHO-DDD
DrugBank.ca
L
IP
CI
Alkeran
Durchstechflasche(n)
72.49
94.35
10 %
: Melphalanum 50 mg
Aspen Pharma Schweiz
GmbH
A / SL / SO
FB
G
L
IP
Melphalan Ideogen 50 mg
57.99
79.50
10 %
Ideogen AG
A / SL / SG
FB
G
L
IP
CI
Alkeran 2 mg
25 Tablet(s)
29.26
48.25
10 %
Coated tablets: Melphalanum 2 mg
Aspen Pharma Schweiz
GmbH
A / SL
FB
G
IP
Phelinun 50 mg
1 +
PR
PR
k.A.
: Melphalanum 50 mg
Adienne SA
A
FB
G
IP
Phelinun 200 mg
1 +
PR
PR
k.A.
: Melphalanum 200 mg
Adienne SA
A
FB
G
Chlormethine (L01AA05) 1 products
WHO-DDD
DrugBank.ca
L
IP
CI
Ledaga
60 g
1538.38
1689.50
10 %
Gel: Chlormethinum 160 µg
Recordati AG
A / SL
FB
G
Ifosfamide (L01AA06) 3 products
WHO-DDD
DrugBank.ca
IP
Holoxan 500 mg
Durchstechflasche(n)
24.57
43.15
10 %
Dry substance: Ifosfamidum 500 mg
Baxter AG
A / SL
FB
G
IP
Holoxan 1 g
Durchstechflasche(n)
42.26
62.40
10 %
Dry substance: Ifosfamidum 1 g
Baxter AG
A / SL
FB
G
IP
Holoxan 2 g
Durchstechflasche(n)
78.62
101.90
10 %
Dry substance: Ifosfamidum 2 g
Baxter AG
A / SL
FB
G
Bendamustine (L01AA09) 18 products
WHO-DDD
DrugBank.ca
L
SIP
IP
Ribomustin 25 mg
Durchstechflasche(n)
58.04
79.20
10 %
Lyophilisate for infusion solution: Bendamustini Hydrochloridum 25 mg
CPS Cito Pharma
Services GmbH
A / SL / SO
FB
G
L
SIP
IP
Ribomustin 25 mg
5 Durchstechflasche(n)
241.17
277.35
10 %
Lyophilisate for infusion solution: Bendamustini Hydrochloridum 25 mg
CPS Cito Pharma
Services GmbH
A / SL / SO
FB
G
L
SIP
IP
Ribomustin 100 mg
Durchstechflasche(n)
187.85
219.65
10 %
Lyophilisate for infusion solution: Bendamustini Hydrochloridum 100 mg
CPS Cito Pharma
Services GmbH
A / SL / SO
FB
G
L
IP
Bendamustin Accord 25 mg
52.76
73.80
10 %
: Bendamustini Hydrochloridum 25 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
Bendamustin Accord 25 mg
5
219.25
254.85
10 %
: Bendamustini Hydrochloridum 25 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
Bendamustin Accord 100 mg
170.78
202.15
10 %
: Bendamustini Hydrochloridum 100 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
Bendamustin Sandoz 25 mg
52.76
73.80
10 %
: Bendamustini Hydrochloridum 25 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
Bendamustin Sandoz 25 mg
5
219.25
254.85
10 %
: Bendamustini Hydrochloridum 25 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
Bendamustin Sandoz 100 mg
170.78
202.15
10 %
: Bendamustini Hydrochloridum 100 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
Bendamustin Accord liquid 100
mg/4 ml
PR
PR
k.A.
Concentrate for infusion: Bendamustinum 100 mg
Accord Healthcare AG
A
FB
G
Bendamustin Accord liquid 100
mg/4 ml
5
PR
PR
k.A.
Concentrate for infusion: Bendamustinum 100 mg
Accord Healthcare AG
A
FB
G
IP
Bendamustin Accord 100 mg
5
PR
PR
k.A.
: Bendamustini Hydrochloridum 100 mg
Accord Healthcare AG
A
FB
G
IP
Bendamustin Sandoz 25 mg
10
PR
PR
k.A.
: Bendamustini Hydrochloridum 25 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Bendamustin Sandoz 25 mg
20
PR
PR
k.A.
: Bendamustini Hydrochloridum 25 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Bendamustin Sandoz 100 mg
5
PR
PR
k.A.
: Bendamustini Hydrochloridum 100 mg
Sandoz
Pharmaceuticals AG
A
FB
G
SIP
IP
Ribomustin 25 mg
10 Durchstechflasche(n)
PR
PR
k.A.
Lyophilisate for infusion solution: Bendamustini Hydrochloridum 25 mg
CPS Cito Pharma
Services GmbH
A
FB
G
SIP
IP
Ribomustin 25 mg
20 Durchstechflasche(n)
PR
PR
k.A.
Lyophilisate for infusion solution: Bendamustini Hydrochloridum 25 mg
CPS Cito Pharma
Services GmbH
A
FB
G
SIP
IP
Ribomustin 100 mg
5 Durchstechflasche(n)
PR
PR
k.A.
Lyophilisate for infusion solution: Bendamustini Hydrochloridum 100 mg
CPS Cito Pharma
Services GmbH
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
